Home | About the eMC | Help | Mobile
eMC - trusted, up to date and comprehensive information about medicines
Link to eMC medicine guides website
eMC homepage
Advanced search
Get Medicines Compendium UK app here

GlaxoSmithKline UK
Stockley Park West, Uxbridge, Middlesex, UB11 1BT
Telephone: +44 (0)800 221 441
Fax: +44 (0)208 990 4328
Medical Information e-mail: customercontactuk@gsk.com

Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?
Patient Information Leaflet last updated on the eMC: 17/01/2012
PIL Pandemrix suspension and emulsion for emulsion for injection

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 17/01/2012 and displayed until Current
Reasons for adding or updating:
  • Change to date of revision
  • Change to warnings or special precautions for use
Updated on 30/09/2011 and displayed until 17/01/2012
Reasons for adding or updating:
  • Change to date of revision
  • Change to, or new, use for medicine
  • Change to side-effects
Updated on 21/02/2011 and displayed until 30/09/2011
Reasons for adding or updating:
  • Change/addition of instructions for reconstitution and/ or administration
  • Correction of spelling/typing errors
Updated on 20/09/2010 and displayed until 21/02/2011
Reasons for adding or updating:
  • Change to Further Information section
  • Change to date of revision
  • Change to side-effects
Updated on 20/08/2010 and displayed until 20/09/2010
Reasons for adding or updating:
  • Change to date of revision
  • Change to, or new, use for medicine
  • Change to warnings or special precautions for use
Updated on 10/03/2010 and displayed until 20/08/2010
Reasons for adding or updating:
  • Improved Electronic Presentation
Updated on 05/03/2010 and displayed until 10/03/2010
Reasons for adding or updating:
  • Change to date of revision
  • Change to side-effects
Updated on 26/01/2010 and displayed until 05/03/2010
Reasons for adding or updating:
  • Improved Electronic Presentation
Updated on 26/01/2010 and displayed until 26/01/2010
Reasons for adding or updating:
  • Improved Electronic Presentation
  • Change to date of revision
Updated on 26/10/2009 and displayed until 26/01/2010
Reasons for adding or updating:
  • New PIL for new product
  • PIL Retired pending re-submission

Active Ingredients/Generics

 
  influenza vaccine (split virion, inactivated)